An outpatient procedure may offer a way for the estimated 70% of people who discontinue popular weight-loss drugs to avoid ...

Retatrutide shows big weight loss potential but isn’t FDA-approved. Here’s what to know about its safety and legal risks.

The company argues the offering is a more comprehensive approach to weight management, allowing patients to receive ongoing ...

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...

The Trump administration had planned for insurers to provide cheap weight loss drugs to seniors through a Medicare pilot ...

The FDA has approved the second GLP-1 pill for overweight and obesity. How does it compare to the Wegovy oral pill?

Experts warn popular GLP‑1 drugs may pose added risks for some patients, highlighting the need for medical supervision.

On Tuesday, Amazon unveiled a new GLP-1 management program aimed at simplifying how patients access, and stay on, high-demand ...

Amazon is launching a new GLP-1 program through One Medical and Amazon Pharmacy to streamline access to popular weight-loss ...

The new program will combine One Medical’s primary care services with Amazon Pharmacy’s access to GLP-1 medications, ...

A flag flies above the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. Lilly, a pharmaceutical company, employs more than 12.000 people in Indianapolis and ...

Through Amazon Pharmacy, patients will be able to access medications including Novo Nordisk's Wegovy as well as newer oral ...